2.85
                                            Schlusskurs vom Vortag:
              $3.06
            Offen:
              $3.1
            24-Stunden-Volumen:
                3.34M
            Relative Volume:
              1.51
            Marktkapitalisierung:
                $384.73M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-35.47M
            KGV:
              -5.00
            EPS:
                -0.57
            Netto-Cashflow:
                $-124.27M
            1W Leistung:
              -11.49%
            1M Leistung:
              +4.01%
            6M Leistung:
                +261.13%
            1J Leistung:
              +83.87%
            Prokidney Corp Stock (PROK) Company Profile
Firmenname
                  
                      Prokidney Corp
                    
                Sektor
                  Branche
                  Telefon
                  
                      336-999-7028
                    
                Adresse
                  
                      2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
                    
                Vergleichen Sie PROK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                PROK
                            
                             
                        Prokidney Corp 
                           | 
                    2.85 | 416.09M | 0 | -35.47M | -124.27M | -0.57 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-06-30 | Herabstufung | BofA Securities | Neutral → Underperform | 
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral | 
| 2024-09-10 | Eingeleitet | Guggenheim | Buy | 
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight | 
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral | 
| 2023-07-25 | Eingeleitet | BTIG Research | Buy | 
| 2022-12-21 | Eingeleitet | Jefferies | Buy | 
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight | 
| 2022-10-18 | Eingeleitet | UBS | Buy | 
| 2022-10-14 | Eingeleitet | Citigroup | Buy | 
| 2022-09-23 | Eingeleitet | BofA Securities | Buy | 
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform | 
                    Alle ansehen
                    
                  
                Prokidney Corp Aktie (PROK) Neueste Nachrichten
Will ProKidney Corp. stock beat EPS estimatesQuarterly Profit Summary & Reliable Trade Execution Plans - newser.com
Is now a turning point for ProKidney Corp.Quarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Is ProKidney Corp. stock poised for growthWeekly Trade Summary & Daily Volume Surge Signals - newser.com
Automated trading signals detected on ProKidney Corp.Weekly Trend Recap & AI Driven Stock Movement Reports - newser.com
What candlestick patterns are forming on ProKidney Corp.2025 Performance Recap & Entry Point Strategy Guides - newser.com
Heatmap analysis for ProKidney Corp. and competitorsJuly 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com
What valuation multiples suggest for ProKidney Corp. stockJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
What to expect from ProKidney Corp. in the next 30 daysPortfolio Profit Report & Trade Opportunity Analysis - newser.com
Visual analytics tools that track ProKidney Corp. performancePortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
Will ProKidney Corp. stock recover faster than peersShare Buyback & Verified Momentum Stock Watchlist - newser.com
Will ProKidney Corp. stock go up soonRisk Management & Long-Term Safe Investment Ideas - newser.com
How ProKidney Corp. stock performs in stagflationSwing Trade & Community Trade Idea Sharing - newser.com
What technical charts say about ProKidney Corp. stockJuly 2025 EndofMonth & Growth Oriented Trading Recommendations - newser.com
ProKidney (NASDAQ:PROK) Shares Down 8.2%Should You Sell? - MarketBeat
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference - The Manila Times
Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025 - Investing News Network
Guidance Update: Can ProKidney Corp. stock weather global recessionJuly 2025 Institutional & Daily Risk Controlled Trade Plans - fcp.pa.gov.br
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):